Cite
HARVARD Citation
Leutz, A. et al. (2021). Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment. British journal of dermatology. pp. 548-550. [Online].